4DMedical is trading 5.5% down at A$3.24; available evidence does not establish a specific cause for the decline.
- The company released its Q1 FY27 quarterly report and held its AGM on October 28.
- AGM results disclosed a first strike against the remuneration report; available sources do not show either directly caused the share-price move.